05:19PM 12/08/09
EnVivo Pharmaceuticals Announces Results Showing In-Vivo Reduction Of Aggregated B-Amyloid
Data continues to support EVP-0962 potential for Alzheimer's treatment
09:00AM 12/08/09
Shoppers can save up to 75 percent by combining value-brand products with pre-tax FSA/HSA savings and available employer discounts
10:45AM 11/30/09
StemCyte Licenses Promising IP For Stem Cell Therapy To Treat Stroke
Respected researcher, Professor John Lin, MD PhD, and Academia Sinica, the Most Preeminent Academic Institution of Taiwan, Agree to Exclusive License with Global Cord Blood Leader, StemCyte
09:45AM 11/30/09
NOVAVAX Completes Enrollment In Phase IIa Study Of Seasonal Influenza Vaccine In Older Adults
- Dose-ranging study to compare Novavax's trivalent virus-like-particle (VLP) vaccine to currently marketed flu vaccine, Fluzone(R)
08:05AM 11/30/09
Iowa and Minnesota Served the Healthiest Thanksgiving Feast While South Carolina Indulged
06:00AM 11/27/09
Munck Carter Obtains Complete Defense Verdict In Eastern District Of Texas Patent Infringement Case
04:27PM 11/23/09
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
12:16PM 11/10/09
Bristol Licenses Arthritis Drug: BioBuzz
Worldwide deal involves privately held Alder BioTherapeutics
09:20AM 11/10/09
Cel-Sci's Mystery Booster Writes Again
In a new article, Dr. Pablo Romanus tries to defend his reputation without addressing directly any of the questions raised about his true identity.
09:28AM 10/13/09
Real Estate Funds Break Out, Led by Direxion
Real estate funds jumped during the past week, driven by a bevy of positive news about the property market.
12:24PM 09/18/09
Cramer: Preaching to the Nonbelievers
This is the greatest rally of my lifetime and it ain't over yet.
07:10AM 09/11/09
Preaching to the Nonbelievers (RealMoney.com $)
This is greatest rally of my lifetime and it ain't over yet.
04:37PM 09/10/09
Novavax's Declining Revenue Widens Loss
The drug company's net loss widened to $11 million in the fourth quarter as revenue plunged 82%.
02:30PM 04/01/09



Connect with TheStreet